Fortuna Fix takes in $25 mln Series B
Fortuna Fix, a Canadian regenerative medicine company, has raised $25 million in Series B financing. The investors included Amgen Ventures.
8 November 2017•1 min read
Fortuna Fix, a Canadian regenerative medicine company, has raised $25 million in Series B financing. The investors included Amgen Ventures.
